Let's talk medical research

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It primarily affects young and middle-aged men, and 80% of patients with PSC also have inflammatory bowel disease (IBD).

Helping patients find out about clinical trials is one of the chief pillars of the work Antidote does, and one of the ways we do this is through our partners. By building a network of nonprofits and patient advocacy groups, we are able to reach patients where they are and help them find clinical trial opportunities that may be a good fit.

In the age of the internet, effective clinical trial digital advertising is imperative to finding the right participants for a research study. Being able to reach patients where they are using outreach material that resonates is vital — but it doesn’t happen without smart, data-driven strategies.

Persistent corneal epithelial defects are more than just an eye injury. The corneal epithelium is an integral part of the eye, tasked with guarding against infection and structural damage. While most injuries to the corneal epithelium are able to heal within a week, these persistent injuries will continue well past the seven-day mark. If they remain unresponsive to standard treatments, the ...

One of the key challenges in medical research is successful patient enrollment. It is not uncommon for trials to fall behind schedule due to low patient engagement — but by creating a recruitment and enrollment strategy centered on patient-centricity, more successful research processes can be made possible. Below, we are exploring some of the top ways to do just that.

Primary biliary cholangitis (PBC) is a rare, chronic liver disease that impacts 58 out of every 100,000 women and 15 out of every 100,000 men in the United States. It typically progresses slowly, exhibiting no symptoms during the first several years — but in later stages, it can cause debilitating symptoms such as fatigue, itchiness, abdominal pain, swelling of the limbs, jaundice, osteoporosis, ...

At Antidote, our mission is to connect patients with clinical trials is only possible when we understand the individuals that make up the patient population. One way we are able to gain this understanding is by providing our clinical trial search tool, Antidote Match, at no cost to over 300 organizations that we partner with.

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.

At Antidote, our primary mission is to make a connection between patients and clinical trial enrollment opportunities. Our key tool for achieving this goal is Antidote Match, a unique and proprietary clinical trial search platform. By answering a few questions, users are able to quickly see which trials they may be eligible for — and this is made possible through the Antidote annotation process. ...

IgA nephropathy, also known as IgAN or Berger disease, is a common kidney disease that can impact any individual at any age. It is one of the most prevalent kidney diseases other than those caused by diabetes or high blood pressure, but the cause and the cure for this condition remain unknown.